Life Science Reagents

LenioBio develops ALiCE®, a scalable eukaryotic cell-free protein expression system that produces complex proteins within 24 hours. The platform enables rapid manufacturing of vaccine-relevant proteins, antibodies, virus-like particles, and membrane proteins, reducing traditional production timelines by approximately 75%. ALiCE® supports applications from research through clinical-scale biomanufacturing, with yields up to 3mg/ml and seamless scaling from microliter to liter volumes.

Benchling is a cloud-based R&D platform serving 200,000+ scientists across 1,200+ biotechnology and pharmaceutical companies, including more than half of the world's top 50 biopharma companies. The unified platform integrates electronic lab notebooks (ELN), laboratory information management systems (LIMS), molecular biology design tools, and bioprocess development capabilities. Benchling enables end-to-end workflows from lead discovery through IND submission, with AI-powered capabilities for protein structure prediction and data analytics.

BioPharmaSpec is a global contract research organization (CRO) specializing in structural and physicochemical analysis of biopharmaceuticals using advanced chromatographic, electrophoretic, and mass spectrometric techniques. They support protein characterization for monoclonal antibodies, antibody-drug conjugates (ADCs), therapeutic peptides, cell and gene therapies, oligonucleotides, and biosimilars, meeting global regulatory requirements like ICH Q6B. With over 45 years of expertise and new facilities in Europe equipped with state-of-the-art instrumentation, they offer comprehensive services including comparability testing, HCP identification, and gap analysis of existing data.

GenScript is a leading biotechnology company specializing in early drug discovery and development services. The company provides comprehensive solutions including gene synthesis, protein production, antibody development, gene editing, and cell/gene therapy support. GenScript offers customizable services with high-speed production capabilities and round-the-clock responsiveness to support pharmaceutical R&D and biologics manufacturing.

ENPICOM provides a unified bioinformatics platform that integrates large-scale biologics data, AI models, and ML frameworks for lab and data scientists in antibody discovery and development. The platform eliminates data silos, enables instant access to sequencing datasets, and supports seamless integration with LIMS, ELNs, and cloud storage via a comprehensive API. They also offer immune repertoire sequencing (Rep-Seq) analysis services using the ImmunoGenomiX (IGX) platform, leveraging expertise in immunology and bioinformatics.

Europa Biosite is a leading pan-European distributor of high-quality research-use-only (RUO) life science reagents, chemicals, and biological substances, offering access to over ten million products including antibodies, biochemicals, diagnostic kits, and ethically sourced biospecimens. Headquartered in Stockholm, the company operates in 17 countries across Europe and North America, supporting over 60,000 academic and biopharma researchers. It comprises six key distribution companies and focuses on locally-tailored commercial solutions for suppliers.

BD Biosciences offers flow cytometry instruments, reagents, and software for clinical and research applications in life sciences and pharma. Their portfolio includes high-performing flow cytometers like BD FACS and BD FACSLyric systems, supporting immunophenotyping, cytokine detection, single-cell multiomics, and cell analysis up to 60 parameters. With over 50 years of expertise, they provide integrated solutions for immunology, oncology, metabolic diseases, and diagnostics.

Fluidic Sciences offers in-solution technologies for protein interaction analysis, including the Fluidity One-M instrument using Microfluidic Diffusional Sizing (MDS) to measure binding affinity, stoichiometry, size, and concentration without immobilization in complex matrices like serum and plasma. Following its acquisition of Sphere Bio's assets in September 2025, the company provides an integrated portfolio of picodroplet microfluidic platforms, consumables, and reagents for high-throughput single-cell screening, isolation, and biologics discovery. These solutions support biotherapeutic development, cell engineering, and synthetic biology workflows.

Fortis Life Sciences provides custom design, validation, and manufacturing solutions for diagnostics and life science organizations, acting as an extension of technical and R&D teams. The company offers capabilities across antibodies, diagnostic components, molecular biology reagents, engineered nanoparticles, and viral vector platforms. They specialize in process development for ultra-sensitive quantitative diagnostic assays and components like quality control materials and blood separation solutions to streamline workflows.

Just - Evotec Biologics is a CDMO providing end-to-end development and cGMP manufacturing for antibodies, next-generation biologics, and biosimilars. They specialize in continuous manufacturing technology to reduce costs and improve access to affordable biotherapeutics, with facilities in Seattle, Redmond (US), and Toulouse (France). Services span discovery using AI platforms like J.HAL and J.MD, process development, and clinical-to-commercial production up to 2,000+ kg/year.

Biotium is a leading manufacturer of high-quality fluorescent dyes, bioconjugates, antibodies, and kits for molecular and cellular biology research. They offer CF® Dyes for labeling, phalloidin conjugates like ActinBrite™ for F-actin staining, MitoView™ mitochondrial dyes, nuclear stains, and cellular stains for organelles and structures. Products support applications including super-resolution microscopy, immunofluorescence, flow cytometry, and education.

Horizon Discovery provides cell engineering tools and services using gene editing technologies like CRISPR, base editing, and RNAi for basic research, drug discovery, and therapeutic development. Their offerings include research reagents, screening and cell line engineering services, BioProduction cell lines for biologics manufacturing, and reference standards for diagnostics. These solutions support gene function studies, target identification, pathway exploration, and precision medicine applications.

TransCure bioServices specializes in humanized mouse models and preclinical CRO services for immuno-oncology, infectious diseases, and inflammatory conditions. They offer advanced platforms including flow cytometry, IHC, imaging, in vitro assays, and diverse models such as CDX in humanized mice, conventional strains, and orthotopic tumors. With over 12 years of expertise, they provide flexible, high-quality studies to accelerate pharmaceutical research.

Hybrigenics Services offers fee-for-service R&D support with proprietary ULTImate Y2H platforms for protein-protein, drug-protein interaction studies, and target identification in drug discovery. They provide custom synthetic VHH nanobody selection, validation, and affinity maturation using their Hybribody library, animal-free process. Services extend to fundamental research, agrosciences, and partnerships with pharma, biotechs, and academia across therapeutic areas like oncology.

Serimmune is an immune intelligence company providing advanced serum antibody profiling through its proprietary SERA (Serum Epitope Repertoire Analysis) platform. The company combines bacterial display peptide library technology, next-generation sequencing, and machine learning to deliver comprehensive immune response mapping for diagnostics, vaccine development, and therapeutic research. Serimmune's capabilities include precision Lyme disease diagnostics, Long COVID immune profiling, and pathogen exposure assessment from minimal serum samples. Now part of Infinity Bio, the company continues expanding its epitope profiling and antibody reactome services for pharmaceutical and research applications.

ImmuneOncia Therapeutics is a clinical-stage biopharmaceutical company specializing in immuno-oncology, developing novel antibodies and bispecific antibodies targeting PD-L1, CD47, and other pathways for cancers like refractory NK/T-cell lymphoma and hepatocellular carcinoma. Key pipeline candidates include Danburstotug (PD-L1 mAb) advancing to Phase III with Lonza manufacturing support, IMC-002 (anti-CD47), and IOH-001 (CD47/PD-L1 bispecific). The company leverages expertise in drug development and antibody engineering from its headquarters in Yongin-si, South Korea.

Immuto Scientific provides an AI-enabled, high-throughput platform combining mass spectrometry and machine learning for structural surfaceomics analysis, identifying novel disease-specific protein conformations (SPCs) as therapeutic targets, particularly for cancer. The company offers contract research services to support drug discovery against undruggable targets, including patented Plasma-Induced Modification of Biomolecules (PLIMB) technology for assessing drug-target binding. They collaborate with institutions like UW-Madison on colorectal cancer target discovery and advance an internal pipeline of biologics and ADCs for indications such as AML, solid tumors, and NSCLC.

Ingenza is an engineering biology CRDMO specializing in industrial biotechnology and synthetic biology to deliver scalable bioprocesses for high-value industrial and therapeutic proteins. They offer microbial and mammalian manufacturing platforms, integrating chemical and biological processes for enhanced productivity. Services include proof-of-concept studies, fermentation development, cell line development, enzyme optimization, and AI/ML-driven protein expression tuning via their inGenius and codABLE platforms.

BellBrook Labs supplies biochemical HTS assay kits, including kinase assay kits, for high-throughput screening in drug discovery. These kits support enzyme activity, receptor binding, and target validation in miniaturized formats like 96-, 384-, and 1536-well plates. They enable pharma and life sciences teams to rapidly test compound libraries, profile selectivity, and advance hit-to-lead progression using robust detection methods such as fluorescence, luminescence, and TR-FRET.

I&L Biosystems is a leading supplier of high-quality laboratory equipment, reagents, and consumables for pharmaceutical, biotechnology, and life sciences markets. The company specializes in fermentation, cell cultivation, bioprocess technology, and analysis instruments ranging from laboratory scale to plant-scale systems. I&L Biosystems distributes innovative solutions including automated chromatography systems for protein purification and serves pharmaceutical R&D, academic institutions, and food safety sectors.

AMSBIO provides cutting-edge life science reagents and services, including specialist antibodies, peptides, recombinant proteins, and extracellular matrices for cell motility, migration, invasion, and proliferation studies. The company supports key research areas such as oncology, regenerative medicine, stem cell biology, glycomics, and cytotoxicity screening with molecular detection reagents and biorepository products like tissue DNA, RNA, and proteins. Founded in 1987, AMSBIO partners globally with offices in the UK, US, Netherlands, and Switzerland to accelerate discovery in medical, nutrition, cosmetics, and energy industries.

Unchained Labs provides innovative tools and AI-driven automation platforms for biologics and gene therapy researchers, including sample preparation, liquid handling, stability screening, and protein quantification. Key products like Stuntman enable natural-language prompted experiments with closed-loop automation, while instruments such as Aunty, Lunatic, and Hound support formulation development, stability analysis, and regulatory-compliant workflows. These solutions accelerate R&D by addressing limitations in traditional lab tools.

LGC is an international life sciences measurement and tools company providing mission-critical components for pharmaceutical, genomic, and quality assurance applications. The company offers reference materials, reagent components, quality management tools, and analytical testing products backed by over 180 years of scientific heritage. LGC operates across 14 countries and serves pharmaceutical, biotechnology, food, environment, and regulatory sectors with solutions for diagnostics, advanced therapeutics, and safety compliance.

LifeArc provides intellectual property management, technology development, early-stage drug discovery, antibody humanization, and diagnostics development services to academic, biotech, and pharmaceutical organizations. It offers funding, partnerships, and commercialization support to translate research into therapies, with successes including pembrolizumab and lecanemab. Profits are reinvested into further medical research focused on rare diseases and global health challenges.